The current state of HIV therapy

Incidence of human immunodeficiency viws (HIV) has decreased dramatically since its emergence in the early 1980s, but it remains a wotidwide epidemic. There is a reduction in newly diagnosed patients, but prevalence is increasing due to a longer life expectancy, which is attñbuted in part to highly...

Full description

Saved in:
Bibliographic Details
Published in:Formulary (Cleveland, Ohio) Ohio), 2013-07, Vol.48 (7), p.213
Main Authors: Benzer, Jessica A, Riley, Ted K, Lee, Jean C
Format: Article
Language:English
Subjects:
Acquired immune deficiency syndrome
AIDS
Anti-HIV agents
Antiretroviral drugs
Antiviral agents
Deoxyribonucleic acid
Disease
DNA
Dosage and administration
Drug interactions
Drug resistance
Drug therapy
Enzymes
Food
Forecasts and trends
Highly active antiretroviral therapy
HIV
HIV infection
Human immunodeficiency virus
Immune system
Management
Medical research
Mortality
Prescription drugs
Prevention
Proteins
Ribonucleic acid
RNA
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Incidence of human immunodeficiency viws (HIV) has decreased dramatically since its emergence in the early 1980s, but it remains a wotidwide epidemic. There is a reduction in newly diagnosed patients, but prevalence is increasing due to a longer life expectancy, which is attñbuted in part to highly effective antiretroviral therapies. Newly approved and investigational antiretroviral therapies provide additional options for the healthcare team to prevent progression of disease as well as transmission of HIV. Early detection and prevention of HIV is still paramount with the use of in-home HIV testing as well as antiretrovirals for pre-exposure prophylaxis. While many advances in HIV diagnosis and treatment have been made, the importance of education and risk avoidance cannot be underestimated. [PUBLICATION ABSTRACT]
ISSN:1082-801X
1938-1166